6.1.1.15	Aneurysm	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27216312&form=6&db=m	Validation of the Simbionix PROcedure Rehearsal Studio sizing module: A comparison of software for endovascular aneurysm repair sizing and planning.	therapeutic application,unassigned	1,0	
6.1.1.15	Carcinogenesis	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27612429&form=6&db=m	EPRS is a critical regulator of cell proliferation and estrogen signaling in ER+ breast cancer.	causal interaction,unassigned	3,0	
6.1.1.15	Coccidiosis	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28867614&form=6&db=m	Targeting Prolyl-tRNA Synthetase to Accelerate Drug Discovery against Malaria, Leishmaniasis, Toxoplasmosis, Cryptosporidiosis, and Coccidiosis.	therapeutic application,unassigned	4,0	
6.1.1.15	Coinfection	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30521835&form=6&db=m	A potent prolyl tRNA synthetase inhibitor antagonizes Chikungunya and Dengue viruses.	therapeutic application,unassigned	1,0	
6.1.1.15	COVID-19	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33791697&form=6&db=m	The Prolyl-tRNA Synthetase Inhibitor Halofuginone Inhibits SARS-CoV-2 Infection.	causal interaction,ongoing research,therapeutic application,unassigned	1,2,4,0	
6.1.1.15	Cryptosporidiosis	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28867614&form=6&db=m	Targeting Prolyl-tRNA Synthetase to Accelerate Drug Discovery against Malaria, Leishmaniasis, Toxoplasmosis, Cryptosporidiosis, and Coccidiosis.	therapeutic application,unassigned	4,0	
6.1.1.15	Dengue	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30521835&form=6&db=m	A potent prolyl tRNA synthetase inhibitor antagonizes Chikungunya and Dengue viruses.	therapeutic application,unassigned	1,0	
6.1.1.15	Diffuse Cerebral Sclerosis of Schilder	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25629079&form=6&db=m	Whole exome sequencing reveals mutations in NARS2 and PARS2, encoding the mitochondrial asparaginyl-tRNA synthetase and prolyl-tRNA synthetase, in patients with Alpers syndrome.	causal interaction,unassigned	1,0	
6.1.1.15	Diffuse Cerebral Sclerosis of Schilder	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29915213&form=6&db=m	The genotypic and phenotypic spectrum of PARS2-related infantile-onset encephalopathy.	causal interaction,unassigned	1,0	
6.1.1.15	Gastroenteritis	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25759500&form=6&db=m	Identification of a gamma interferon-activated inhibitor of translation-like RNA motif at the 3' end of the transmissible gastroenteritis coronavirus genome modulating innate immune response.	unassigned	-